Hannerieke van den Hout

Hannerieke van den Hout is a researcher in the Department of Pediatrics at Erasmus MC, Faculty of Medicine. Her work is centered on rare metabolic and lysosomal storage disorders, with a strong focus on Pompe disease and enzyme replacement therapy.

Research Interests: Dr. van den Hout's research spans rare diseases, metabolic disorders, and patient-centered outcomes. She investigates clinical pathways, treatment efficacy, and quality of life in children with Pompe disease. Her work contributes to international guidelines through collaborations with MetabERN and the European Pompe Consortium.

Publication Trends: Her recent publications emphasize clinical recommendations, patient registries, and therapeutic strategies for rare diseases. The research integrates neurology, pediatrics, and pharmacology, with a growing focus on multistakeholder data systems and evidence-based treatment criteria.

Scientific Contributions:

• Active contributor to clinical guidelines for Pompe disease
• Key participant in European rare disease networks
• Research on health-related quality of life in pediatric rare disease populations

Advising and Grants: While specific grant details are not listed, her involvement in large consortia suggests participation in funded collaborative projects. She has supervised at least two research works, indicating an active mentoring role.

Labs and Teams: Dr. van den Hout collaborates within Erasmus MC’s pediatric research unit and is part of international networks including the European Pompe Consortium and MetabERN’s Lysosomal Disorders subnetwork, contributing to coordinated research and clinical standardization efforts.